Paul Newhouse
Last active: 3/3/2020

  1. Sex differences in psychophysical and neurophysiological responses to pain in older adults: a cross-sectional study. Monroe TB, Gore JC, Bruehl SP, Benningfield MM, Dietrich MS, Chen LM, Newhouse P, Fillingim R, Chodkowski B, Atalla S, Arrieta J, Damon SM, Blackford JU, Cowan RL (2015) Biol Sex Differ : 25
    › Primary publication · 26579217 (PubMed) · PMC4647695 (PubMed Central)
  2. Impaired working memory in geriatric depression: an FMRI study. Dumas JA, Newhouse PA (2015) Am J Geriatr Psychiatry 23(4): 433-436
    › Primary publication · 25458072 (PubMed)
  3. Estrogen, Stress, and Depression: A Neurocognitive Model. Newhouse P, Albert K (2015) JAMA Psychiatry 72(7): 727-9
    › Primary publication · 26018188 (PubMed)
  4. Estrogen-cholinergic interactions: Implications for cognitive aging. Newhouse P, Dumas J (2015) Horm Behav : 173-85
    › Primary publication · 26187712 (PubMed) · PMC4573353 (PubMed Central)
  5. Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle. Albert K, Pruessner J, Newhouse P (2015) Psychoneuroendocrinology : 14-24
    › Primary publication · 26123902 (PubMed) · PMC4492530 (PubMed Central)
  6. Epidemiology of MRI-defined vascular depression: A longitudinal, community-based study in Korean elders. Park JH, Lee SB, Lee JJ, Yoon JC, Han JW, Kim TH, Jeong HG, Newhouse PA, Taylor WD, Kim JH, Woo JI, Kim KW (2015) J Affect Disord : 200-6
    › Primary publication · 25913805 (PubMed)
  7. Deficits in audiovisual speech perception in normal aging emerge at the level of whole-word recognition. Stevenson RA, Nelms CE, Baum SH, Zurkovsky L, Barense MD, Newhouse PA, Wallace MT (2015) Neurobiol Aging 36(1): 283-91
    › Primary publication · 25282337 (PubMed) · PMC4268368 (PubMed Central)
  8. Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Vega JN, Newhouse PA (2014) Curr Psychiatry Rep 16(10): 490
    › Primary publication · 25160795 (PubMed) · PMC4169219 (PubMed Central)
  9. AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adults. Potter AS, Dunbar G, Mazzulla E, Hosford D, Newhouse PA (2014) Biol Psychiatry 75(3): 207-14
    › Primary publication · 23856296 (PubMed)
  10. A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Jucaite A, Öhd J, Potter AS, Jaeger J, Karlsson P, Hannesdottir K, Boström E, Newhouse PA, Paulsson B (2014) Psychopharmacology (Berl) 231(6): 1251-65
    › Primary publication · 23640072 (PubMed) · PMC3838503 (PubMed Central)